Back to today’s briefing

Story perspectives

Breakthrough TAR-200 Chemotherapy Shows Promise in Bladder Cancer

8/23/2025

46 4

Summary

Story summary

A clinical trial for TAR-200, a new chemotherapy delivery method, shows promising results for bladder cancer.
Conducted by Keck Medicine of USC, the trial involved 85 patients, with cancer disappearing in 70 cases after three months.
Nearly 50% of patients remained cancer-free after one year.
This treatment minimizes side effects and may enhance outcomes for high-risk patients.

1 of 1

Story summary

A clinical trial for TAR-200, a new chemotherapy delivery method, shows promising results for bladder cancer.
Conducted by Keck Medicine of USC, the trial involved 85 patients, with cancer disappearing in 70 cases after three months.
Nearly 50% of patients remained cancer-free after one year.
This treatment minimizes side effects and may enhance outcomes for high-risk patients.